Radiotherapy-Resistant Pediatric Bladder Rhabdomyosarcoma: A Case Report

Wigati Dhamiyati; Sri Retna Dwidanarti; Torana Kurniawan; Ericko Ekaputra; Lidya Mediana; Seize Edwiena Yanuarta

doi:10.32532/jori.v13i2.151

Radiotherapy-Resistant Pediatric Bladder Rhabdomyosarcoma: A Case Report

Wigati Dhamiyati, Sri Retna Dwidanarti, Torana Kurniawan, Ericko Ekaputra, Lidya Mediana, Seize Edwiena Yanuarta

Sari

Abstract

Introduction : Rhabdomyosarcoma (RMS) is a type of malignancy that is relatively rare and originates from soft tissue. RMS can appear at any age but is most common in children and toddlers. Rhabdomyosarcoma managed use chemotherapy as the main modality, followed by surgery or radiation if there was residual or recurrence.

Case Presentation : In this report, the author will review a case of radioresponsiveness pediatric bladder rhabdomyosarcoma

The patient received chemotherapy with cyclophosphamide-mesna, vincristine, and actinomycin. After chemotherapy, the mass was reduced partially and then followed by whole bladder external radiation.

Conclusions :

Rhabdomyosarcoma in the child's bladder may exhibit radioresistance characteristics

Keywords : rhabdomyosarcoma, radiation, pediatric, bladder

Kata Kunci

rhabdomyosarcoma; radiation; pediatric; bladder

Teks Lengkap:

PDF (English)

Referensi

Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, et al. Intergroup Rhabdomyosarcoma Study-IV: Results for patients with nonmetastatic disease. J Clin Oncol. 2001;19(12):3091–102.

Halperin EC, Wazer DE, Perez CA, Brady LW. Principles and Practices of Radiation Oncology. 7th ed. Halperin EC, Wazer DE, Perez CA, Brady LW, editors. Philadelphia: Wolters Kluwer; 2018.

Marshall AG. Rhabdomyosarcoma of the Urinary Bladder. Br Med J. 1948;2(4578):662.

Pater LE, Breneman J, Wolden S, Donaldson S. Rhabdomyosarcoma Review 2017: Children’s Oncology Group. 2017;

Esiashvili N, Prabhu R, Kahn S, Paulino AC. Current strategies and challenges in treatment of childhood rhabdomyosarcoma. J Radiat Oncol. 2013;2(2):159–68.

Terezakis SA, Wharam MD. Radiotherapy for Rhabdomyosarcoma: Indications and Outcome. Clin Oncol [Internet]. 2013;25(1):27–35. Available from: http://dx.doi.org/10.1016/j.clon.2012.07.009

Ashlock R, Johnstone PAS. Treatment modalities of bladder/prostate rhabdomyosarcoma: A review. Prostate Cancer Prostatic Dis. 2003;6(2):112–20.

Hristov B, Lin SH, Christodouleas JP. Radiation Oncology A Question-Based Review. 3rd Editio. Hristov B, Lin SH, Christodouleas JP, editors. Philadelphia: Wolters Kluwer; 2018.

Breneman J, Meza J, Donaldson SS, Raney RB, Wolden S, Michalski J, et al. Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: A report from the Children’S Oncology Group D9602 study. Int J Radiat Oncol Biol Phys [Internet]. 2012;83(2):720–6. Available from: http://dx.doi.org/10.1016/j.ijrobp.2011.06.2011

Petragnano F, Pietrantoni I, Camero S, Codenotti S, Milazzo L, Vulcano F, et al. Clinically relevant radioresistant rhabdomyosarcoma cell lines: Functional, molecular and immune-related characterization. J Biomed Sci. 2020;27(1):1–18.

DOI: https://doi.org/10.32532/jori.v13i2.151 <